Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, Wos EJ, Moore DF, Kugler JW, Windschitl HE, Graham DL, Bernath AM Jr, Fitch TR, Soori GS, Jett JR, Adjei AA, Perez EA. Johnson EA, et al. Among authors: marks rs. Lung Cancer. 2008 May;60(2):200-7. doi: 10.1016/j.lungcan.2007.10.003. Epub 2007 Nov 28. Lung Cancer. 2008. PMID: 18045731 Clinical Trial.
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H. Sawyer TE, et al. Among authors: marks rs. Cancer. 1997 Oct 15;80(8):1399-408. doi: 10.1002/(sici)1097-0142(19971015)80:8<1399::aid-cncr6>3.0.co;2-a. Cancer. 1997. PMID: 9338463
Phase II trial of topotecan for the treatment of mesothelioma.
Maksymiuk AW, Marschke RF Jr, Tazelaar HD, Grill J, Nair S, Marks RS, Brooks BJ, Mailliard JA, Burton GM, Jett JR. Maksymiuk AW, et al. Among authors: marks rs. Am J Clin Oncol. 1998 Dec;21(6):610-3. doi: 10.1097/00000421-199812000-00017. Am J Clin Oncol. 1998. PMID: 9856666 Clinical Trial.
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
Kirschling RJ, Grill JP, Marks RS, Kugler JW, Gerstner JB, Kuross SA, Michalak JC, Windschitl HE, Krewer KD, Jett JR. Kirschling RJ, et al. Among authors: marks rs. Am J Clin Oncol. 1999 Oct;22(5):517-22. doi: 10.1097/00000421-199910000-00019. Am J Clin Oncol. 1999. PMID: 10521070 Clinical Trial.
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR. Bonner JA, et al. Among authors: marks rs. J Clin Oncol. 1999 Sep;17(9):2681-91. doi: 10.1200/JCO.1999.17.9.2681. J Clin Oncol. 1999. PMID: 10561342 Clinical Trial.
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ; North Central Cancer Treatment Group. Colon-Otero G, et al. Among authors: marks rs. Am J Clin Oncol. 2001 Dec;24(6):551-5. doi: 10.1097/00000421-200112000-00004. Am J Clin Oncol. 2001. PMID: 11801752 Clinical Trial.
224 results